1. Bess, F., Konrad, J., Paul, N., & Yvonne, A. (2002). Prevalence of peripheral arterial disease: Persistence of excess risk in former smokers. Australian and New Zealand Journal of Public Health, 26(3), 219–224.
2. Criqui, M. H., & Aboyans, V. (2015). Epidemiology of peripheral artery disease. Circulation Research, 116(9), 1509–1526.
3. Gerhard-Herman, M. D., Gornik, H. L., Barrett, C., Barshes, R. N., Corriere, M. A., Drachman, D. E., et al. (2016). AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology, 135(12), 726–779.
4. Manfredini, F., Malagoni, A. M., Felisatti, M., Mandini, S., Mascoli, F., Manfredini, R., et al. (2009). A dynamic objective evaluation of peripheral arterial disease by near-infrared spectroscopy. European Journal of Vascular and Endovascular Surgery, 38(4), 441–448.
5. Lamberti, N., Manfredini, F., Tessari, M., Menegatti, E., Nardi, F., Basaglia, N., et al. (2019). A near-infrared spectroscopy-assisted test discriminates patients with peripheral arterial disease and venous insufficiency with changes of foot oxygenation following light elastic compression therapy. The European Journal of Vascular Medicine, 48(4), 361–367.